KINIKSA PHARMACEUTICALS LTD

CUSIP: G5269C101 Class: Foreign Stock

LOS ANGELES CAPITAL MANAGEMENT LLC's Holding History (CIK: 0001177206)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 139,850 Value ($000) $2,759 Avg Close — Range —
Q4 2023
Shares 147,182 Value ($000) $2,582 Avg Close — Range —
Q3 2023
Shares 145,642 Value ($000) $2,530 Avg Close — Range —
Q2 2023
Shares 160,394 Value ($000) $2,258 Avg Close — Range —
Q1 2023
Shares 113,647 Value ($000) $1,223 Avg Close — Range —
Q4 2022
Shares 117,706 Value ($000) $1,763 Avg Close — Range —
Q3 2022
Shares 122,990 Value ($000) $1,579 Avg Close — Range —
Q2 2022
Shares 65,582 Value ($000) $635 Avg Close — Range —
Q1 2022
Shares 65,322 Value ($000) $649 Avg Close — Range —
Q4 2021
Shares 59,970 Value ($000) $706 Avg Close — Range —
Q3 2021
Shares 32,084 Value ($000) $365 Avg Close — Range —
Q2 2021
Shares 45,776 Value ($000) $638 Avg Close — Range —
Q1 2021
Shares 22,313 Value ($000) $413 Avg Close — Range —
Q4 2020
Shares 28,123 Value ($000) $497 Avg Close — Range —
Q3 2020
Shares 26,532 Value ($000) $406 Avg Close — Range —
Q2 2020
Shares 22,353 Value ($000) $570 Avg Close — Range —
Q1 2020
Shares 17,940 Value ($000) $278 Avg Close — Range —
Q4 2019
Shares 13,040 Value ($000) $144 Avg Close — Range —